All Stories

  1. Design, synthesis, and binding analysis of target-specific covalent inhibitors of SARS-CoV-2 papain-like protease
  2. Reactions of Plasmodium falciparum Type II NADH: Ubiquinone Oxidoreductase with Nonphysiological Quinoidal and Nitroaromatic Oxidants
  3. Broadening the Scope of van Leusen Reaction: Investigation of Benzofuro[2,3‐d]imidazole Formation
  4. Comprehensive analysis of resorcinyl-imidazole Hsp90 inhibitor design
  5. Aortic disease and cardiomyopathy in patients with a novel DNMT3A gene variant causing Tatton-Brown–Rahman syndrome
  6. Recent advances in computational and experimental protein-ligand affinity determination techniques
  7. Biochemical and cellular insights into the Baz2B protein, a non-catalytic subunit of the chromatin remodeling complex
  8. 4H-[1,3,5,2]Oxadiazaphospholo[3,4-a][1,5]benzodiazepin-1-amine-1-oxides: Synthesis and Computational Studies
  9. Understanding the activity of glucose oxidase after exposure to organic solvents
  10. Enhanced nucleosome assembly at CpG sites containing an extended 5-methylcytosine analogue
  11. Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases
  12. Polyester Dendrimers Based on Bis-MPA for Doxorubicin Delivery
  13. Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9
  14. Structure and mechanism of secondary sulfonamide binding to carbonic anhydrases
  15. Isoform-Selective Enzyme Inhibitors by Exploring Pocket Size According to the Lock-and-Key Principle
  16. The hydrolysis of indoxyl acetate: A versatile reaction to assay carbonic anhydrase activity by high-throughput screening
  17. Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics
  18. Template‐based modeling of diverse protein interactions in CAPRI rounds 38‐45
  19. Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs
  20. Engineered Carbonic Anhydrase VI-Mimic Enzyme Switched the Structure and Affinities of Inhibitors
  21. Binding affinity in drug design: experimental and computational techniques
  22. In Silico Modeling of Inhibitor Binding to Carbonic Anhydrases
  23. Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors
  24. Genome scale metabolic models as tools for drug design and personalized medicine
  25. Molecular basis for potentiation of Cx36 gap junction channel conductance by n -alcohols and general anesthetics
  26. Acetylcholine molecular arrays enable quantum information processing
  27. Predicting Isoform-specific Binding Selectivities of Benzensulfonamides Using QSAR and 3D-QSAR
  28. Fluorinated benzenesulfonamide anticancer inhibitors of carbonic anhydrase IX exhibit lower toxic effects on zebrafish embryonic development than ethoxzolamide
  29. Spintronic characteristics of self-assembled neurotransmitter acetylcholine molecular complexes enable quantum information processing in neural networks and brain
  30. COD::CIF::Parser: an error-correcting CIF parser for the Perl language
  31. CLEA-Based Immobilization of Methylotropic Yeast Alcohol Oxidase: Influence on Storage Stability and Reaction Efficiency
  32. Comparing several methods in predicting of binding affinity of ligands to carbonic anhydrase
  33. Synthesis and antiproliferative activity of α-branched α,β-unsaturated ketones in human hematological and solid cancer cell lines
  34. Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII
  35. Discovery and Characterization of Novel Selective Inhibitors of Carbonic Anhydrase IX
  36. Conformational Analysis of Processivity Clamps in Solution Demonstrates that Tertiary Structure Does Not Correlate with Protein Dynamics
  37. Monoclonal antibodies raised against 167–180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity
  38. Saccharin Sulfonamides as Inhibitors of Carbonic Anhydrases I, II, VII, XII, and XIII
  39. Design, Synthesis, Binding, Crystallography, and Docking of [(2-Pyrimidinylthio)Acetyl]Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases
  40. Insight into the role of N,N-dimethylaminoethyl methacrylate (DMAEMA) conjugation onto poly(ethylenimine): cell viability and gene transfection studies
  41. ChemInform Abstract: Design of [(2-Pyrimidinylthio)acetyl]benzenesulfonamides as Inhibitors of Human Carbonic Anhydrase.
  42. Enantioseparation and chiral recognition mechanism of new chiral derivatives of xanthones on macrocyclic antibiotic stationary phases
  43. Structural and functional analysis of rare missense mutations in human chorionic gonadotrophin  -subunit
  44. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases
  45. Interaction of antimicrobial peptides, BP100 and pepR, with model membrane systems as explored by brownian dynamics simulations on a coarse-grained model
  46. Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance
  47. Toward the Design of Mutation-Resistant Enzyme Inhibitors: Further Evaluation of the Substrate Envelope Hypothesis
  48. Study on the cyclization of 6-arylethynylpyrimidine-5-carbaldehydes with tert-butylamine: microwave versus thermal preparation of pyrido[4,3-d]pyrimidines
  49. Quantitative Structure-Activity Relationship Models with Receptor-Dependent Descriptors for Predicting Peroxisome Proliferator-Activated Receptor Activities of Thiazolidinedione and Oxazolidinedione Derivatives
  50. HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants
  51. Erratum
  52. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease
  53. Design of Mutation-resistant HIV Protease Inhibitors with the Substrate Envelope Hypothesis
  54. SitCon: Binding site residue conservation visualization and protein sequence-to-function tool
  55. Using Protein Homology Models for Structure-Based Studies: Approaches to Model Refinement
  56. Screening Drug-Like Compounds by Docking to Homology Models:  A Systematic Study
  57. Comparing Ligand Interactions with Multiple Receptors via Serial Docking
  58. Structural model for an AxxxG-mediated dimer of surfactant-associated protein C
  59. Solution Structure and Functional Ligand Screening of HI0719, a Highly Conserved Protein from Bacteria to Humans in the YjgF/YER057c/UK114 Family † , ‡
  60. Enhanced docking with the mining minima optimizer: Acceleration and side-chain flexibility
  61. Accurate Intraprotein Electrostatics Derived from First Principles:  An Effective Fragment Potential Method Study of the Proton Affinities of Lysine 55 and Tyrosine 20 in Turkey Ovomucoid Third Domain
  62. The Effective Fragment Potential Method:  A QM-Based MM Approach to Modeling Environmental Effects in Chemistry
  63. QM/MM Boundaries Across Covalent Bonds:  A Frozen Localized Molecular Orbital-Based Approach for the Effective Fragment Potential Method
  64. Evaluation of the charge penetration energy between non-orthogonal molecular orbitals using the Spherical Gaussian Overlap approximation
  65. A quantum chemical cluster study of hydrated halide adsorption on the cathodic Al(111) surface
  66. Computation of adsorbate vibrational frequencies: methyl, methylidyne and methoxy adsorbed on the Al(111) surface
  67. Electric field effects on the geometry and vibrations of charged molecules: the hydroxide ion case
  68. Geometry Optimization of Charged Molecules in an External Electric Field Applied to F - ·H 2 O and I - ·H 2 O
  69. A theoretical investigation of adsorbate-induced surface relaxation effects using cluster models: Al on Si(111)
  70. The mechanism of electroreduction of silver cyanide complexes in aqueous electrolytes—II. Interpretation of SERS data